Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
GE HealthCare Technologies Inc has a consensus price target of $97.69 based on the ratings of 18 analysts. The high is $110 issued by Citigroup on February 13, 2025. The low is $74 issued by UBS on September 26, 2024. The 3 most-recent analyst ratings were released by Goldman Sachs, Wells Fargo, and Citigroup on March 11, 2025, February 14, 2025, and February 13, 2025, respectively. With an average price target of $104.33 between Goldman Sachs, Wells Fargo, and Citigroup, there's an implied 27.62% upside for GE HealthCare Technologies Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
03/11/2025 | Buy Now | 22.32% | Goldman Sachs | David Roman37% | $85 → $100 | Upgrade | Neutral → Buy | Get Alert |
02/14/2025 | Buy Now | 25.99% | Wells Fargo | Larry Biegelsen69% | $96 → $103 | Maintains | Overweight | Get Alert |
02/13/2025 | Buy Now | 34.56% | Citigroup | Joanne Wuensch75% | $103 → $110 | Maintains | Buy | Get Alert |
01/08/2025 | Buy Now | 25.99% | Jefferies | Matthew Taylor67% | $95 → $103 | Upgrade | Hold → Buy | Get Alert |
10/31/2024 | Buy Now | 17.43% | Wells Fargo | Larry Biegelsen69% | $95 → $96 | Maintains | Overweight | Get Alert |
10/01/2024 | Buy Now | 24.77% | Evercore ISI Group | Vijay Kumar53% | $98 → $102 | Maintains | Outperform | Get Alert |
09/30/2024 | Buy Now | 24.77% | Stifel | Rick Wise74% | $100 → $102 | Maintains | Buy | Get Alert |
09/26/2024 | Buy Now | -9.48% | UBS | Graham Doyle49% | $88 → $74 | Downgrade | Neutral → Sell | Get Alert |
09/18/2024 | Buy Now | 22.32% | BTIG | Ryan Zimmerman73% | → $100 | Upgrade | Neutral → Buy | Get Alert |
09/09/2024 | Buy Now | 10.09% | JP Morgan | Robbie Marcus68% | → $90 | Initiates | → Neutral | Get Alert |
08/06/2024 | Buy Now | 22.32% | Stifel | Rick Wise74% | → $100 | Initiates | → Buy | Get Alert |
05/30/2024 | Buy Now | 6.42% | Goldman Sachs | David Roman37% | → $87 | Initiates | → Neutral | Get Alert |
05/01/2024 | Buy Now | 5.2% | B of A Securities | Craig Bijou75% | $94 → $86 | Maintains | Neutral | Get Alert |
05/01/2024 | Buy Now | 28.44% | Mizuho | Anthony Petrone65% | $110 → $105 | Maintains | Buy | Get Alert |
04/11/2024 | Buy Now | 34.56% | Mizuho | Anthony Petrone65% | $96 → $110 | Maintains | Buy | Get Alert |
04/04/2024 | Buy Now | 22.32% | Evercore ISI Group | Vijay Kumar53% | $93 → $100 | Maintains | Outperform | Get Alert |
04/03/2024 | Buy Now | 25.99% | Citigroup | Joanne Wuensch75% | $88 → $103 | Maintains | Buy | Get Alert |
04/01/2024 | Buy Now | 34.56% | Argus Research | David Toung71% | $80 → $110 | Maintains | Buy | Get Alert |
02/15/2024 | Buy Now | 22.32% | HSBC | Sezgi Oezener34% | → $100 | Initiates | → Buy | Get Alert |
02/12/2024 | Buy Now | 5.2% | Morgan Stanley | Patrick Wood54% | $74 → $86 | Maintains | Equal-Weight | Get Alert |
02/12/2024 | Buy Now | 7.65% | UBS | Graham Doyle49% | $66 → $88 | Upgrade | Sell → Neutral | Get Alert |
02/07/2024 | Buy Now | 17.43% | Mizuho | Anthony Petrone65% | $94 → $96 | Maintains | Buy | Get Alert |
12/04/2023 | Buy Now | -9.48% | Morgan Stanley | Patrick Wood54% | $78 → $74 | Maintains | Equal-Weight | Get Alert |
11/30/2023 | Buy Now | -2.14% | Jefferies | Matthew Taylor67% | → $80 | Initiates | → Hold | Get Alert |
11/27/2023 | Buy Now | -19.27% | UBS | Graham Doyle49% | $86 → $66 | Downgrade | Neutral → Sell | Get Alert |
09/19/2023 | Buy Now | 0.31% | Citigroup | Joanne Wuensch75% | → $82 | Initiates | → Buy | Get Alert |
08/16/2023 | Buy Now | 10.09% | Wells Fargo | Larry Biegelsen69% | → $90 | Initiates | → Overweight | Get Alert |
07/31/2023 | Buy Now | 0.31% | B of A Securities | Craig Bijou75% | → $82 | Initiates | → Neutral | Get Alert |
07/26/2023 | Buy Now | -4.59% | Morgan Stanley | Patrick Wood54% | $76 → $78 | Maintains | Equal-Weight | Get Alert |
06/28/2023 | Buy Now | -7.03% | Morgan Stanley | Patrick Wood54% | → $76 | Initiates | → Equal-Weight | Get Alert |
06/27/2023 | Buy Now | -7.03% | Morgan Stanley | Patrick Wood54% | → $76 | Initiates | → Equal-Weight | Get Alert |
05/16/2023 | Buy Now | 18.65% | Oppenheimer | Suraj Kalia55% | → $97 | Initiates | → Outperform | Get Alert |
04/26/2023 | Buy Now | 14.98% | Mizuho | Anthony Petrone65% | $92 → $94 | Maintains | Buy | Get Alert |
04/26/2023 | Buy Now | 5.2% | UBS | Graham Doyle49% | → $86 | Initiates | → Neutral | Get Alert |
04/19/2023 | Buy Now | 16.21% | Piper Sandler | Jason Bednar54% | → $95 | Initiates | → Overweight | Get Alert |
04/18/2023 | Buy Now | 12.54% | Mizuho | Anthony Petrone65% | $90 → $92 | Maintains | Buy | Get Alert |
04/10/2023 | Buy Now | — | BTIG | Ryan Zimmerman73% | — | Initiates | → Neutral | Get Alert |
03/13/2023 | Buy Now | 10.09% | Evercore ISI Group | Vijay Kumar53% | → $90 | Initiates | → Outperform | Get Alert |
02/17/2023 | Buy Now | 10.09% | Mizuho | Anthony Petrone65% | → $90 | Initiates | → Buy | Get Alert |
01/19/2023 | Buy Now | — | Redburn Partners | Ed Ridley-Day66% | — | Initiates | → Buy | Get Alert |
01/04/2023 | Buy Now | — | Edward Jones | John Boylan73% | — | Initiates | → Hold | Get Alert |
The latest price target for GE HealthCare Techs (NASDAQ:GEHC) was reported by Goldman Sachs on March 11, 2025. The analyst firm set a price target for $100.00 expecting GEHC to rise to within 12 months (a possible 22.32% upside). 18 analyst firms have reported ratings in the last year.
The latest analyst rating for GE HealthCare Techs (NASDAQ:GEHC) was provided by Goldman Sachs, and GE HealthCare Techs upgraded their buy rating.
The last upgrade for GE HealthCare Technologies Inc happened on March 11, 2025 when Goldman Sachs raised their price target to $100. Goldman Sachs previously had a neutral for GE HealthCare Technologies Inc.
The last downgrade for GE HealthCare Technologies Inc happened on September 26, 2024 when UBS changed their price target from $84 to $74 for GE HealthCare Technologies Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GE HealthCare Techs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GE HealthCare Techs was filed on March 11, 2025 so you should expect the next rating to be made available sometime around March 11, 2026.
While ratings are subjective and will change, the latest GE HealthCare Techs (GEHC) rating was a upgraded with a price target of $85.00 to $100.00. The current price GE HealthCare Techs (GEHC) is trading at is $81.75, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.